Laurent Pharmaceuticals
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1010 Sherbrooke St West Ste 2401, Montre...Phone Number
(514) 513-2252Website
www.laurentpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Laurent Pharmaceuticals
Laurent Pharma is a clinical stage biotech company dedicated to developing treatments for complex conditions resulting from an unbalanced immune-inflammatory response. The company focuses on the modulation of cell membrane lipids and has over 10 years of clinical development experience with its drug candidate, LAU-7b, currently in Phase 2 clinical trials. Laurent Pharma aims to address high unmet medical needs by targeting multiple molecular pathways to treat degenerative conditions. Their intended clients include healthcare providers and patients seeking innovative therapies for challenging medical issues.Explore more
Laurent Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Laurent Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Laurent Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Laurent Pharmaceuticals has new funding data
Laurent Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Laurent Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Laurent Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Laurent Pharmaceuticals
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Laurent Pharmaceuticals launches new products
Click to see if Laurent Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Laurent Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Laurent Pharmaceuticals
Compare insights from companies similar to Laurent Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Laurent Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Laurent Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Laurent Pharmaceuticals.
Laurent Pharmaceuticals financials insights
Gather financial insights about Laurent Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Unspecified
$2M
Laurent Pharmaceuticals Tech Stack
A closer look at the technologies used by Laurent Pharmaceuticals
See more technologies
Laurent Pharmaceuticals News & Media
Laurent Pharmaceuticals Presents Results from Phase 2 Clinical Study of LAU-7b in Cystic Fibrosis at the NACFC 2022
MONTREAL--(BUSINESS WIRE)--Laurent Pharmaceuticals Inc. (the “Company”), a clinical-stage biopharmaceutical company developing LAU-7b (oral fenretinide) as a first-in-class inflammation-controlling drug candidate for Cystic Fibrosis (CF), announces the presentation of results from its placebo-controlled Phase 2 APPLAUD 24-week clinical study in adults with CF at the North American Cystic Fibrosis Conference (NACFC) currently held in Philadelphia, United States. Study results achieved a statistiLaurent Pharmaceuticals Starts Phase 3 Study With Once-a-Day Oral COVID-19 Antiviral Treatment Candidate in Hospitalized Moderate-to-Severe Patients
MONTREAL--(BUSINESS WIRE)--Laurent Pharmaceuticals Starts Phase 3 Study with Once-a-Day Oral COVID-19 Antiviral Treatment Candidate in Hospitalized Moderate-to-Severe PatientsLaurent Pharmaceuticals Extends COVID-19 Phase 2 Study with Oral Antiviral LAU-7b that has Showed 100% Reduction in the Risk of Progression onto Mechanical Ventilation and Death
MONTREAL--(BUSINESS WIRE)--Laurent Pharma extends COVID-19 Ph 2 study with oral antiviral LAU-7b that has showed 100% reduction in the risk of mechanical ventilation and deathLaurent Pharmaceuticals Announces Topline Results from its Phase 2 RESOLUTION Clinical Trial of LAU-7b for the Treatment of COVID-19
MONTREAL--(BUSINESS WIRE)--Laurent Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing LAU-7b, a first-in-class pro-resolving drug candidate, reported today topline results from its Phase 2 RESOLUTION clinical trial in hospitalized COVID-19 patients. This double-blind, placebo-controlled trial evaluated the efficacy and safety of once-a-day oral LAU-7b, administered for 14 days on top of standard of care. The trial randomized a total of 232 hospitalized patients with mod
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Laurent Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Laurent Pharma is a clinical stage biotech company dedicated to developing treatments for complex conditions resulting from an unbalanced immune-inflammatory response. The company focuses on the modulation of cell membrane lipids and has over 10 years of clinical development experience with its drug candidate, LAU-7b, currently in Phase 2 clinical... Read More
